Sparrow2 schreef op 3 augustus 2017 11:19:
[...]
Onvoltrokken feit niet. Maar...
Op 7 juli post Barron's het volgende artikel
"Galapagos Is More Attractive–But Don’t Buy It Just Yet" -
"That’s the conclusion of Janney Capital’s Debjit Chattopadhyay: He upgraded Galapagos to Neutral from Sell on Friday, citing the fact that the stock has underperformed the SPDR S&P Biotech ETF (XBI) by some 30% in the past few months, and is now close to his fair value estimate of $74."
Fair value = $74 = 62,55 euro
Verder nieuwe rating:
28/07/2017 Broker: Stifel Nicolaus Rating:
Hold New Target: $83.0000 Maintain
Nog steeds geen Buy rating he en dit is een recent analystenbureau.
Dan op 1 augustus: "A Reversal for Galapagos NV Ads (NASDAQ:GLPG) Is Not Near. The Stock Has Rise in Shorts" - The stock of Galapagos NV Ads (NASDAQ:GLPG) registered an increase of 39.55% in short interest. GLPG’s total short interest was 805,900 shares in August as published by FINRA. Its up 39.55% from 577,500 shares, reported previously. With 171,100 shares average volume, it will take short sellers 5 days to cover their GLPG’s short positions. The short interest to Galapagos NV Ads’s float is 2.46%.
Dus, a.u.b. geeft u mij eens een indicatie dat wat ik komt te stellen 'onmogelijk' is ? Ik hoor het graag.